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Six proteolytic enzymes, including alcalase, flavourzyme, trypsin, neutrase, papain and pepsin, were 
employed to hydrolyze cottonseed protein to produce the hydrolysates of Angiotensin I-converting 
enzyme (ACE) inhibitory activity. The result indicated that the cottonseed protein hydrolysate (CPH) 
produced by papain had the highest ACE inhibitory activity. Therefore, papain was selected for 
enzymatic production of ACE inhibitor from cottonseed protein isolates (CPI). CPI was hydrolyzed with 
papain for 1 - 8 h, and the 6 h hydrolysate had the strongest ACE inhibitory ability. The product was 
separated into four ranges of molecular weight (UF-I, > 30 kDa; UF-II, 30 – 10 kDa; UF - III, 10 - 5 kDa; UF - 
IV, < 5 kDa) by using an ultrafiltration (UF) membrane bioreactor system. Among them, UF-IV showed the 
highest ACE inhibitory activity (IC50 = 0.792 mg/ml). UF-IV was further fractionated with Sephadex G-25 
gel filtration chromatography into four fractions (Fra I, Fra II, Fra III and Fra IV) that were composed of 
peptides of >2.43 kDa, 2.43 - 0.82 kDa, 0.82 - 0.35 kDa and <0.35 kDa, respectively. Fra II exhibited the 
strongest ACE inhibitory ability (IC50 = 0.159 mg/ml) with the yield of 41.63%. It was suggested that Fra II 
with good ACE inhibitory activity can be a potential source of natural ACE inhibitor.  
 






Hypentension is now a major problem threatening people 
health in the world. It is a risk factor for developing 
cardiovascular diseases (arteriosclerosis, stroke and 
myocardial infraction) and end-stage renal disease, and is 
often called a “silent killer” because persons with hyper- 
tension are often asymptomatic for years. It was 
estimated that there is about 15-20% of adults suffering 
from hypertension (Je et al., 2005). Since the past two 
decades, the renin-angiotensin system (RAS) has been 
found to be a coordinated peptidic hormonal cascade for  
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of cardiovascular, renal and adrenal functions governing 
fluid and electrolyte balance and arterial blood pressure 
(Carey and Siragy, 2003). Briefly, prorenin is converted to 
active renin by a trypsin-like enzyme. Renin cleaves 
angio- tensinogen to form angiotensin I. Angiotensin 
I-converting enzyme (ACE) hydrolyses both the inactive 
angiotensin I into vasoconstrictor angiotensin II and the 
vasodilator bradikinin into an inactive metabolite. Most 
well-known effects of angiotensin II, including 
vasoconstriction, are mediated by angiotensin type 1 
receptors (AT1). Angio- tensin II also binds to angiotensin 
type 2 receptors (AT2) which are highly expressed in 
foetal mesenchymal tissues but poorly expressed in the 
adult. So angiotensin I-converting enzyme (ACE, kinase II, 
EC 3.4.15.1) is potentially of great importance for controlling 
blood pressure by virtue of the rennin-angiotensin system. 
Although synthetic ACE inhibitors, including captopril, 
enalapril and lisinopril, are remarkably effective as 
antihypertensive drugs, they cause adverse side effects 
such as dry cough, angio-oedema and many other 
disfunctions of human organs (Fitzgerald and Meisel, 
2000).  




Therefore, to find safe and natural ACE inhibitors are 
desirable for the prevention and remedy of hypertension. 
Recently, peptides showing antihypertensive activity as 
inhibitors of ACE have been obtained from the proteolysis 
products of several food proteins such as casein, whey 
protein, gelatin, kidney bean protein, buckwheat protein, 
corn protein and soybean protein etc (Tauzin et al., 2002; 
Abubakar et al., 1998; Kim et al., 2001; Lee et al., 1999; Li 
et al., 2002; Suh et al., 2003). Though these peptides are 
less potent than synthetic ones, they do not exhibit known 
side effects. 
Cotton is not only the most important fibre crop in the 
world but also the second best potential source of plant 
proteins after soybean (Ahmad et al., 2007). Cottonseed 
proteins are widely regarded as potential sources of 
nutrients for humans and animals, and have also been a 
subject for numerous investigations (Ory and Flick, 1994). 
In China, about 10 million tons of cottonseeds are 
produced annually. The presence of toxic gossypol in the 
cottonseed is a limiting factor for human consumption and 
various methods have been proposed for reduction of free 
gossypol content to the allowable limit of 450 ppm (FDA 
regulations, 1974).  
Oshima et al. (1979) first reported ACE inhibitory pep- 
tides produced from food protein by digestive proteases. 
Afterward, many other ACE inhibitory peptides have been 
discovered from enzymatic hydrolysates of different food 
proteins. However, to our knowledge, there is no report 
about ACE inhibitory effect from cottonseed protein hydro- 
lysate. In the present study, the ACE inhibitory activities of 
cottonseed protein hydrolysates were produced with 
different enzymes. The ultrafiltration membrane and gel 
filtration (Sephadex G-25) were used to isolate the high 








Dephenol cottonseed meal (65% protein) was obtained from China 
Cotton-Unis Co. (Beijing, China). Neutrase, flavourzyme, alcalase 
and papain were from Novo ezymes Co. (Novo Nordisk, Bagsvaerd, 
Denmark). Trypsin, pepsin, ACE enzyme powder and hippuryl-L- 
histidyl-L-leucine (HHL) were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). Ultrafiltration membranes, including 5, 10 and 
30 kDa, were purchased from Millipore Co. (Bedford, MA, USA). All 
other reagents used were of analytical grade. 
 
 
Production of cottonseed protein isolates (CPI) 
 
The CPI was prepared according to the method reported by Tunc 
and Duman (2007) with little modification. First, the defatted and 
dephenol cottonseed flour was mixed with distilled water at a ratio of 
1:15 (w/v). Then the pH was adjusted to 10.5 with 0.1 M NaOH, the 
mixture was stirred for at least 2 h. At this point, the mixture was 
centrifuged at 8,000 g for 15 min. The precipitate was mixed with 
distilled water (1:5, w/v) and the pH was adjusted to 10.5 and then 





collected and the pH was adjusted to 4.3 with 0.1 M HCl in order to 
precipitate cottonseed protein isolate, which was lyophilized and 
stored at –20°C. 
 
 
Proteases hydrolysis of CPI 
 
Alcalase, flavourzyme, trypsin, neutrase, papain and pepsin were 
employed in this study. 1% (w/w of CPI) protease was added to 
5.0% (w/v) CPI to produce hydrolysates, and the ACE inhibitory 
activity of hydrolysate from different enzyme was compared. The 
optimum reaction conditions of temperature and pH for each enzy- 
me were followed by the instruction of the supplier, such as 55°C 
and pH 9.0 for alcalase, 45°C and pH 7.0 for flavourzyme, 37°C and 
pH 7.0 for trypsin, 50°C and pH 7.5 for neutrase, 45°C and pH 7.0 
for papain, and 37°C and pH 4.0 for pepsin, respectively. The 
samples were heated in a water bath at 90°C for 15 min prior to 
enzymatic hydrolysis and hydrolyzed with the enzyme for 6 h. Then 
the enzyme was inactivated by heating at 95°C for 15 min when the 
reaction was finished. The resulting hydrolysates were rapidly 
cooled to ambient temperature in the ice bath and centrifuged at 
8,000 g for 15 min. The supernatants were collected to determine 
the ACE inhibitory activity. 
 
 
Degree of hydrolysis (DH) 
 
In this study, the DH of cottenseed protein hydrolyzed with papain 
was determined by using a pH-stat method (Alder-Nissen, 1986) at 
1 h intervals based on the equation: 
 
DH = (h / htot) × 100%  
 
Where, h = B × Nb × 1/a × 1/MP, B = base consumption (ml), Nb = 
concentration of base (1 M NaOH), 1/a = calibration factors for 
pH-stat, MP = mass of protein (g), and h = hydrolysis equivalents. 
For cottonseed protein, htot = 7.21 mmol/g.  
 
 
ACE inhibitory activity assay  
 
ACE inhibitory activity was measured by the hippuric acid method 
(Cushman and Cheung, 1971) with modification. The reaction 
mixture contained 100 l of 5 mM HHL as a substrate, 150 l of ACE 
solution (0.025 U/ml) and 50 l of the sample solution. The reaction 
was carried at 37°C for 60 min, and terminated by addition of 250 l 
of 1 N HCl. The hippuric acid formed was extracted with ethyl 
acetate (1.5 ml), and after removal of ethyl acetate by heat 
evaporation, hippuric acid was redissolved in 1 M NaCl (3 ml) and 
the absorbance was measured at 228 nm by UltroSpec 4300 pro 
UV/visible spectrophotometer (Pharmacia Co, USA). The inhibition 
activity was calculated using the following equation: 
 
Inhibition activity (%) = [(Ac – As / (Ac – Ab)] ×100  
 
Where, Ac is the absorbance of the buffer (control), As is the 
absorbance of the reaction mixture (sample), Ab is the absorbance 
when the stop solution was added before the reaction occurred 
(blank). The IC50 value was defined as the concentration of peptide 
in mg/ml required to reduce 50% of ACE activity, which was 




Ultrafiltration preparation of cottonseed protein hydrolysate 
(CPH) 
 





Table 1. ACE inhibitory activities of CPH fractionated 
by ultrafiltration. 
 
Sample IC50 (mg protein/ml) 
CPH  5.26 ± 0.140 
UF-I ( >30 kDa) 7.83 ± 0.352 
UF-II (30 – 10 kDa) 2.76 ± 0.030 
UF-III (10 – 5kDa)  1.73 ± 0.036 
UF- IV ( <5 kDa) 0.792 ± 0.079 
 




enzyme ratio to 100:1 (w/w) at 45°C for 8 h (pH 7.0). The enzyme 
was inactivated by heating at 95°C for 15 min when the reaction was 
finished. The resultant CPH was fractionated into 4 parts (UF-I, UF-II, 
UF-III, UF-IV) by the ultrafiltration membrane bioreactor system with 
30, 10 and 5 kDa of molecular weight cut-offs (MWCO). UF-I was 
not passed through the 30 kDa membrane. UF-II was passed 
through the 30 kDa membrane but not passed through the 10 kDa 
membrane. UF-III passed through the 10 kDa membrane but not the 
5 kDa membrane. UF- IV was passed through the 5 kDa membrane. 
All of UF fractions were lyophilized in a freeze-drier for ACE 
inhibitory activity tests. 
 
 
Size exclusion chromatography 
 
UF-IV with the highest activity among the fractions (Table 1) was 
separated on a Sephadex G-25 (1.5 × 90 cm) column by using 
AKTA purifier (Amersham pharmacia biotech Co, USA). Phosphate 
buffer solution (10 mM, pH 7.4) was used to equilibrate the column 
and to elute the proteins at a flow rate of 0.2 ml/min. A fixed amount 
of sample (1.0 ml) at a protein concentration of 10 mg/ml was 
applied to the column, and the absorbance of the effluent was 
measured at 215 nm. A molecular weight calibration curve was 
made according to the following standards: bovine serum albumin 
(66 kDa), lysozyme (14.4 kDa), insulin from bovine pancreas (5.7 
kDa), vitamin B12 (1.355 kDa), oxidized glutathione (0.612 kDa) and 
reduced glutathione (0.307 kDa). The fractions of CPH were lyoph- 





Data were obtained as the mean and standard deviation (SD) and 
analyzed using one-way analysis of variance (ANOVA) by the 
statistical package for the social sciences (SPSS) version 13.0 for 
windows. Difference in mean values were considered significant 
when P < 0.05. 
 
 
RESULTS AND DISCUSSION 
 
Effect of different protease hydrolyses on ACE 
inhibitory activity 
 
CPI was hydrolyzed by alcalase, flavourzyme, trypsin, 
neutrase, papain and pepsin for 6 h, respectively. Figure 1 
shows the ACE inhibitory activities of the different protease 
hydrolysates. The hydrolysate produced by hydrolyzing 
CPI with papain exhibited strongest ACE inhibitory activities 
(85.61%), and the others in turn were  pepsin  
(74.38%), 




flavourzyme (54.93%), neutrase (52.88%), trypsin (51.23%) 
and alcalase (35.03%). Therefore, the choice of proteases 
for generating ACE inhibitory activity is very important. 
Papain is a commercial protease for industrial use and 
has been employed to hydrolyze many kinds of proteins, 
such as whey, plasma, albumin, casein, gelatin and some 
plant proteins to produce bioactive peptides, so it was 
selected for further study on enzymatic production of ACE 
inhibitor from CPI. 
 
 
DH and ACE inhibitory activity of papain-hydrolysate 
 
In the protein hydrolysis, it is necessary to have a 
measure to determine the extent of hydrolytic degradation. 
The degree of DH is defined as the percentage ratio of the 
number of peptide bonds broken (h) to the total number of 
bonds per unit weight (htot). DH is generally used as a 
proteolysis monitoring parameter, and it is the most widely 
used indicator for comparison among different protein 
hydrolysates (Alder-Nissen, 1986). The DH of hydrolyzing 
CPI with papain increased almost linearly (P < 0.05) with 
increasing hydrolysis time in the first 4 h, and reached a 
plateau at 26.2 – 27.5% after 4 h (Figure 2). The ACE 
inhibitory activity increased when CPI was hydrolyzed by 
papain from 1 to 6 h, but decreased steadily from 6 to 8 h. 
Further treatment may result in the hydrolysis of the ACE 
inhibitory peptides into amino acids with a lost the ACE 
inhibitory activity. As a result, 6 h was the optimum 
hydrolysis time in our work, which was consistent with the 
result reported by Mullally et al. (1997), they also found 
that the ACE inhibitory activity was released during the 
first hydrolysis reaction time and further digestion did not 
result to an increased development of inhibitory activity.  
 
 
ACE inhibitory activities of the hydrolysate and 
ultrafiltration fractions 
 
CPH prepared from hydrolysis of CPI with papain was 
collected for further fractionation of active peptides by 
ultrafiltration. As shown in Table 1, CPH was fractionated 
into UF-I (>30 kDa), UF-II (30–10 kDa), UF-III (10–5 kDa) 
and UF-IV (below 5 kDa). Table 1 also shows that ACE 
inhibitory activities of UF fractions varied with the molecular 
mass distribution, the ACE inhibitory activity increased 
with decreasing cut-off MW, indicating the relatively low 
MW of ACE inhibitory peptides. The UF-IV with MW below 
5 kDa showed the most potent ACE inhibitory activity with 
an IC50 value of 0.792 mg/ ml. The membrane module 
with 5 kDa of molecular cut-off was applied for production 
of ACE inhibitor from CPI. 
Won-Kyo et al. (2006) reported that yellowfin sole 
(Limanda aspera) frame protein hydrolysate were frac- 
tionated into three ranges of molecular weight (YFPH-I, 3 
0-10 kDa; FPH-II, 10-5 kDa; YFPH-III, below 5 kDa) using 
an ultrafiltration membrane bioreactor system. It was  found 





























Figure 1. The ACE inhibitory activity of different protease hydrolyses. Means with different letters (a – f) 
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Figure 2. DH of CPI treated with papain and ACE inhibitory activity of the hydrolysates. Means with 
different letters (a – h) are significantly different (P < 0.05). 










Table 2. The ACE inhibitory activity and yield of the fractions obtained on a Sephadex G-25 column. 
 
Test sample Sample molecular weight ACE IC50 (mg/ml) Recovery yield (%) 
Fraction I  >2430 Da 1.197 ± 0.008 36.43 ± 0.121 
Fraction II 816 - 2430 Da 0.159 ± 0.007 41.63 ± 0.192 
Fraction III 345 - 816 Da 0.815 ± 0.020 10.88 ± 0.078 
Fraction IV <345 Da 1.086 ± 0.014 9.36 ± 0.069 
 




that the 5 kDa permeate fraction had strongest ACE 
inhibitory activity with an IC50 value of 0.883 mg/ml. 
Moreover, Wang et al. (2007) reported that wheat gluten 
hydrolysate prepared by papain was se- parated through 
an ultrafiltration membrane with a molecular weight cut-off 
of 5 kDa and found that the 5 kDa permeate fraction had 
the strongest antioxidant activity. The results mentioned 
above indicated that the 5 kDa ultrafiltration membrane 
was often used to produce bioactive peptides. 
 
 
ACE inhibitory activities of the fractions fractionated 
with gel filtration 
 
The UF-IV fraction (below 5 kDa) with highest ACE 
inhibitory activity was fractionated by gel filtration column 
chromatography on Sephadex G-25 at 215 nm (Figure 3). 
The UF-IV was successfully separated into four fractions 
(Fra I, Fra II, Fra III and Fra IV), corresponding to 
molecular weights of >2.42 kDa, 2.4 – 0.82 kDa, 0.82 – 
0.35 kDa, and <0.35 kDa (Table 2). The fractions asso- 
ciated with the peaks were collected, concentrated and 
evaluated for ACE inhibitory activity. Table 2 shows the 
peptide yield as well as the ACE inhibitory activity for the 
various fractions. When the ACE inhibitory activity was 
tested in all fractions, fraction II (2.4 – 0.82 KDa) exhibited 
the highest activity with an IC50 value of 0.159 mg/ml and 
its yield was 41.63%. Matsui et al. (2002) reported that 
single oral administration of royal jelly protein hydroly- 
sates with IC50 value of 0.099 mg protein/ml in 10-week 
spontaneously hypertensive rats resulted in a significant 
reduction of systolic blood pressure. Wen-Dee et al. (2006) 
found that soy protein hydrolysate prepared by alcalase 
could reduce its IC50 value from 66.4 to 1.79 mg 
protein/ml in 1 h of hydrolysis. Mullally et al. (1996) 
concluded that the tryptic casein of the IC50 values ranging  




from 0.130 to 0.201 mg/ml had potential application as 
nutraceuticals in the prevention of hyper- tension. Wu and 
Ding (2002) characterized the soy protein derived ACE 
inhibitor peptides and suggested that the most economic 
way to market the peptides was as contained in the crude 
protein hydrolysate for consum- ption on a long-term 
basis for desired therapeutic effects. In our work, fraction 
II derived from cottonseed protein with strong ACE 
inhibitory activity (IC50 = 0.159 mg/ml) and higher yield 
(41.63%) could mediate an antihy- pertensive effect and 





ACE inhibitors have been developed to prevent angio- 
tensin II production in cardiovascular diseases and 
utilized in clinical applications since the discovery of ACE 
inhibitor in snake venom (Ferreira et al., 1970). In this 
study, the peptides were produced by hydrolysis of 
cottonseed protein with different protease, including 
alcalase, flavourzyme, trypsin, neutrase, papain and 
pepsin. The most potent ACE inhibitory activity hydroly- 
sate was obtained by papain hydrolysis of CPH. Further, 
the papain-hydroylsate was separated with ultrafiltration 
into 4 parts (UF-I, UF-II, UF-III, UF-IV); the ACE inhibitory 
activity (IC50) of the hydrolysate decreased from 5.26 to 
0.792 mg protein/ml. The UF-IV was successfully 
fractionated into four fractions (Fra I, Fra II, Fra III and Fra 
IV) by gel filtration column chromatography on Sephadex 
G-25. The results revealed that fraction II has the highest 
ACE inhibitory activity (IC50 = 0.159 ml/mg) and higher 
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